Psychometric properties and use of the DEMQOL suite of instruments in research: a systematic review protocol by Hoben, Matthias et al.
Psychometric properties and use of the DEMQOL suite of 
instruments in research: a systematic review protocol
Article  (Published Version)
http://sro.sussex.ac.uk
Hoben, Matthias, Chamberlain, Stephanie A, O'Rourke, Hannah M, Elliott, Brittany, Shrestha, 
Shovana, Devkota, Rashmi, Thorne, Trina, Lam, Jenny, Banerjee, Sube, Hughes, Laura and 
Estabrooks, Carole A (2021) Psychometric properties and use of the DEMQOL suite of 
instruments in research: a systematic review protocol. BMJ Open, 11. e041318 1-10. ISSN 2044-
6055 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/101804/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 
1Hoben M, et al. BMJ Open 2021;11:e041318. doi:10.1136/bmjopen-2020-041318
Open access 
Psychometric properties and use of the 
DEMQOL suite of instruments in 
research: a systematic review protocol
Matthias Hoben   ,1 Stephanie A Chamberlain,2 Hannah M O'Rourke,1 
Brittany Elliott,1 Shovana Shrestha,1 Rashmi Devkota,1 Trina Thorne,1 Jenny Lam,1 
Sube Banerjee,3 Laura Hughes   ,4 Carole A Estabrooks1
To cite: Hoben M, 
Chamberlain SA, O'Rourke HM, 
et al.  Psychometric properties 
and use of the DEMQOL 
suite of instruments in 
research: a systematic 
review protocol. BMJ Open 
2021;11:e041318. doi:10.1136/
bmjopen-2020-041318
 ► Prepublication history and 
additional material for this paper 
is available online. To view these 
files, please visit the journal 
online (http:// dx. doi. org/ 10. 
1136/ bmjopen- 2020- 041318).
Received 04 June 2020
Revised 20 October 2020
Accepted 18 November 2020
1Faculty of Nursing, University 
of Alberta, Edmonton, Alberta, 
Canada
2Faculty of Medicine and 
Dentistry, University of Alberta, 
Edmonton, Alberta, Canada
3Faculty of Health and Human 
Sciences, University of 
Plymouth, Plymouth, UK
4Centre for Dementia Studies, 
Brighton and Sussex Medical 
School, Brighton, UK
Correspondence to
Dr Matthias Hoben;  
 mhoben@ ualberta. ca
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction Dementia is a public health issue and a 
major risk factor for poor quality of life among older adults. 
In the absence of a cure, enhancing health- related quality 
of life (HRQoL) of people with dementia is the primary goal 
of care. Robust measurement of HRQoL is a prerequisite to 
effective improvement. The DEMQOL suite of instruments 
is considered among the best available to measure 
HRQoL in people with dementia; however, no review has 
systematically and comprehensively examined the use 
of the DEMQOL in research and summarised evidence to 
determine its feasibility, acceptability and appropriateness 
for use in research and practice.
Methods and analysis We will systematically search 12 
electronic databases and reference lists of all included 
studies. We will include systematically conducted reviews, 
as well as, quantitative and qualitative research studies 
that report on the development, validation or use in 
research studies of any of the DEMQOL instruments. 
Two reviewers will independently screen all studies for 
eligibility, and assess the quality of each included study 
using one of four validated checklists appropriate for 
different study designs. Discrepancies at all stages of 
the review will be resolved by consensus. We will use 
descriptive statistics (frequencies, proportions, ranges), 
content analysis of narrative data and vote counting (for 
the measures of association) to summarise the data 
elements. Using narrative synthesis, we will summarise 
what is known about the development, validation, 
feasibility, acceptability, appropriateness and use of the 
DEMQOL. Our review methods will follow the reporting 
and conduct guidelines of the Cochrane Handbook for 
Systematic Reviews of Interventions and the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analysis.
Ethics and dissemination Ethical approval is not 
required as this project does not involve primary data 
collection. We will disseminate our findings through peer- 
reviewed publications and conference presentations.
PROSPERO registration number CRD42020157851.
INTRODUCTION
Health- related quality of life (HRQoL) is a key 
outcome in dementia care and research.1–3 
With no dementia cure or disease- modifying 
treatment available, maximising HRQoL of 
people with dementia is the overarching goal 
of care.4–6 Dementia is an umbrella term for 
a set of progressive, degenerative brain disor-
ders that successively diminish a person’s 
cognitive and functional abilities. Dementia 
is associated with troubling neuro- psychiatric 
symptoms, and is, ultimately, fatal.7 8 Currently, 
50 million people worldwide are living with 
dementia9—500 000 in Canada,10 5.7 million 
in the USA11 and 9.6 million in the EU.12 
Numbers are expected to be more than triple 
by 2050.9 People with dementia experience 
decline in physical function and mental 
health, often associated with poor HRQoL.7 13
Although often used interchangeably, 
QoL and HRQoL are related but distinct 
Strengths and limitations of this study
 ► In contrast to systematic reviews synthesising ev-
idence on multiple health- related quality of life 
(HRQoL) instruments, our review will investigate in 
detail the evidence available on one specific instru-
ment to measure dementia- related HRQoL—the 
DEMQOL suite of instruments—allowing for a suf-
ficiently detailed analysis of all relevant aspects of 
the selected instrument.
 ► We will identify, evaluate and synthesise evidence 
on the psychometric properties of the DEMQOL 
suite of instruments, its feasibility, acceptability, ap-
propriateness and on how it was used in research 
studies—which is a prerequisite to determine its 
strengths and weaknesses for use in research and 
care practice, and to identify important research 
gaps.
 ► We will apply best practices in conducting system-
atic reviews, guided by the Cochrane Handbook of 
Systematic Reviews and the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses 
guidelines.
 ► We expect that we will not be able to conduct meta- 
analyses since we likely will not be able to identify 
a minimum of three studies investigating the same 
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concepts.14 QoL has been conceptualised as a person’s 
overall general well- being, including physical, material, 
social and emotional components, rated based on the 
person’s subjective perception (self- report) but may also 
include objective indicators (eg, observation of some-
one’s behaviour or affect).14 QoL is influenced by factors 
that interact in complex ways: physical health, psycholog-
ical state, personal beliefs, social relationships and envi-
ronmental features.1 Often terms like ‘well- being’, ‘life 
satisfaction’ or ‘comfort’ are either used to define QoL, 
treated as synonymous to QoL or considered similar but 
distinct concepts.15 Authors disagree on whether QoL 
should be rated purely based on a person’s individual 
perception (self- report) or if it also should include objec-
tive indicators (eg, observation of someone’s behaviour 
or affect).14 Therefore, it is critical that authors clearly 
report the definition underlying their research. Our 
understanding of QoL is based on the WHO’s definition 
of QoL as ‘an individual’s perception of their position 
in life in the context of the culture and value systems in 
which they live and in relation to their goals, expecta-
tions, standards and concerns’ (The WHOQOL Group,16 
p1405).
Building on the concept of QoL but narrowing the 
focus, HRQoL in contrast is defined as an individual’s 
perception of the impact a health condition has on that 
individual’s life.17 This is the definition that the DEMQOL 
suite of instruments18 is based on—a set of question-
naires to measure HRQoL in people with dementia. The 
DEMQOL suite of instruments will be the focus of this 
review. HRQoL and common dementia symptoms (cogni-
tive and physical impairment and neuro- psychiatric symp-
toms) are related, but they are not the same.19 People with 
dementia can have good HRQoL despite severe cognitive 
and physical impairment, and people with mild dementia 
symptoms can have poor HRQoL.19 Therefore, measuring 
a person’s perceptions of how symptoms affect their life 
(HRQoL), rather than just dementia symptom severity, 
can provide more specific information about how to best 
promote well- being in ways that are most meaningful to 
the person with dementia.
Systematic reviews are available on (a) tools to assess 
HRQoL in people with dementia in general2 20 or (b) 
in care homes,3 21 (c) generic QoL tools for use in care 
homes22 and (d) QoL and HRQoL tools that have been 
used in clinical trials for interventions targeting people 
living with dementia or cognitive impairment.23 These 
reviews have identified 34 tools to assess QoL or HRQoL 
in people with dementia (table 1). Another popular tool 
not captured in any of these reviews is the interRAI QoL 
module.24 Evidence for reliability and validity for many of 
these instruments is poor and, in general, there is high 
heterogeneity in terms of the tools’ theoretical founda-
tions, domains measured, and how they apply to different 
levels of dementia severity.2 20 21 It is unclear which of these 
instruments is most feasible, acceptable or appropriate 
for use in research and practice.2In line with best practice 
standards for evaluating the psychometric properties of 
Table 1 Overview of tools available to assess QoL or 
HRQoL in people with dementia
Acronym Full name
– Activity and Affect rating scales
ACSA Anamnestic Comparative Self‐
Assessment Scale
ADRQL Alzheimer Disease Related Quality of 
Life
BASQID Bath Assessment of Subjective Quality 
of Life in Dementia
– Byrne–MacLean QoL Index
CBS Cornell- Brown Scale
CDQLP Community Dementia Quality of Life 
Profile
COOP/WONCA Cooperative Functional Health 
Assessment Charts/World Organization 
of National Colleges, Academies and 
Academic Associations of General 
Practitioners/Family Physicians
DCM Dementia Care Mapping
DEMQOL –
DQoL Dementia Quality of life
EQ- 5D/EQ- 15D –
H.I.L.DE. Heidelberg Instrument to assess Quality 
of Life in people with dementia
HUI3 Health Utilities Index Mark 3
MCQ Mild Cognitive Impairment Questionnaire
OQOLD (A) Observing Quality of Life in Dementia 
(also a version for advanced (A) 
dementia available)
PDS Progressive Deterioration Scale
PES- AD Pleasant Events Schedule
PGC- ARS Philadelphia Geriatric Center Affect 
Rating Scale
PGCMS Philadelphia Geriatric Centre Moral 
Scale
– Psychosocial Quality of Life Domains 
Measure
PWB- CIP Psychological Well- Being in Cognitively 
Impaired Persons
QLA- P Quality of Life Assessment—Patient
QOL- AD Quality of Life in Alzheimer’s Disease
QOL- D Quality of Life in Dementia
QOLAS Quality of Life Assessment Schedule
– Quality of Life Face Scale
QOLS Quality of Life Scales
QUALID Quality of Life in Late- stage Dementia
QUALIDEM Quality of life instrument for proxy 
completion
RSOC- QoL Resident and Staff Observation 
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research tools,25 we define reliability as statistical measures 
that indicate how closely two equivalent forms of a tool 
correlate. Validity, according to these standards, is ‘the 
degree to which evidence and theory support the inter-
pretations of test scores for proposed uses of tests’ (AERA 
et al,25 p11). Feasibility, acceptability and appropriateness 
are implementation outcomes—that is, outcomes that 
reflect tool users’ experiences with using the tool and 
their perception of whether the tool can and should be 
used in the future.26 We provide detailed definitions and 
operationalisations of each of these terms in the methods 
section (inclusion/exclusion criteria).
Previous reviews have attempted to give an overview of 
measurement properties and usability across and between 
QoL tools. However, none sufficiently analyse all relevant 
aspects to understand (a) a certain tool’s conceptual 
characteristics, (b) whether that tool is psychometrically 
sound, feasible, acceptable and appropriate for use in 
research and practice and (c) how that tool has been used 
in research as of now. Therefore, we believe that system-
atic reviews examining one selected QoL tool in detail are 
needed.
In this review, we chose to focus on the DEMQOL 
suite of instruments18 for the following reasons. First, 
the DEMQOL suite is specifically designed to measure 
HRQoL among people with dementia. Generic QoL 
tools (eg, EQ5D,27 SF-12,28 interRAI QoL module24 often 
work poorly to capture the perspective of people with 
dementia.18 Second, among the available instruments to 
measure HRQoL in people with dementia, the DEMQOL 
suite is considered one of the best given its relatively 
strong theoretical foundations and psychometric prop-
erties (table 2).2 The DEMQOL and DEMQOL- Proxy 
were developed based on robust theory and a rigorous 
process of tool development that included (a) a review 
of available conceptualisations of QoL and HRQoL, (b) 
a review of available measures of HRQoL in dementia, 
(c) qualitative interviews with people with dementia and 
their families and (d) the development of a conceptual 
framework for dementia- related HRQoL.18 29 Therefore 
content validity is acceptable. In their review, Bowling et 
al2 report evidence for acceptability and feasibility of the 
DEMQOL and DEMQOL- Proxy. Evidence is also avail-
able on convergent and discriminant validity.2 Evidence 
on the tools’ factor structure, responsiveness and respon-
dent burden is limited.2 No evidence is available on 
known group differences and on psychometric proper-
ties of cultural and language adaptations of these tools.2 
The DEMQOL- CH is based on the DEMQOL- Proxy with 
similar findings related to its reliability and validity.30 
Third, the DEMQOL and its variations (proxy versions, 
preference- based indices for use in economic evaluation 
and translations into various languages; table 2)31 are 
among the most popular instruments to measure HRQoL 
in research with people with dementia. As of 23 May 
2020, the developers had documented 89 studies that 
used the DEMQOL suite of instruments.32 Fourth, with 
the DEMQOL- CH,30 a version is now available that can 
be completed by staff caring for residents with dementia 
living in congregate care settings such as nursing homes or 
assisted/supportive living. This is important because the 
majority of these residents have dementia that is severe 
enough to limit their ability to self- report,33–38 and often 
residents do not have a family/friend carer who visits and 
who could provide a proxy assessment.39 A tool that can 
be completed by care staff in a way that is reliable, valid, 
feasible, acceptable and appropriate opens the possibility 
of routine HRQoL assessment—an important prerequi-
site for improving residents’ HRQoL.
No dementia- specific QoL or HRQoL tool has been 
rigorously and comprehensively assessed for reliability, 
validity, feasibility, acceptability, appropriateness and use 
in research, using a comprehensive review of the liter-
ature. Therefore, focusing on the DEMQOL suite of 
instruments, in this review we will answer the following 
research questions:
1. How has the DEMQOL system been used in research?
a. What research questions did studies using the DEM-
QOL system investigate?
b. Which study settings and populations did studies us-
ing the DEMQOL system focus on?
c. What is the quality of the research using the DEM-
QOL system?
2. How has the DEMQOL system been evaluated?
a. What evidence is available on the development of 
the DEMQOL system?
b. What are the psychometric properties of the DEM-
QOL system?
c. What is the evidence on the DEMQOL system’s fea-
sibility, acceptability and appropriateness?
METHODS AND ANALYSIS
Review design
We will conduct a systematic mixed methods synthesis 
of research.40 Our review methods and presentation 
of results will follow the Cochrane Handbook of Systematic 
Reviews of Interventions41 and the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses 
(PRISMA) guidelines.42 This paper follows the PRISMA- P 
reporting guidelines for systematic review protocols.43 We 
started the review in Jan 2019. Currently, we are finalising 
the screening of full texts. The review is scheduled to be 
completed by March 2021.
Patient and public involvement
This systematic review is part of a larger research 
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the HRQoL in people with dementia living in congre-
gate settings. On 09 October 2019, our research team 
convened a policy- level forum on QoL in the Canadian 
province of Alberta,44 including health systems level and 
health ministry level key decision makers, representatives 
from care organisations, people with dementia and their 
family/friend caregivers. The purpose of the forum was 
to develop a framework for improving QoL for persons 
with moderate to severe dementia living in congregate 
care settings. Perspectives of people with dementia and 
their family/friend caregivers were central throughout all 
discussions. Two key outcomes of this forum included: (a) 
a mandate to conduct this systematic review in order to 
further explore suitability of the DEMQOL suite of instru-
ments for routine use in congregate care settings, and (b) 
formation of a QoL workgroup to further advance the 
QoL work started by our team. This workgroup includes 
representatives of all stakeholder groups involved in the 
QoL forum and oversees the various activities of our team, 
including this systematic review. We will feed back results 
of this review to the QoL workgroup and to the larger 
team on an ongoing basis, and this review will inform 
Table 2 Overview of DEMQOL versions and their characteristics
DEMQOL DEMQOL- Proxy DEMQOL- U DEMQOL- Proxy- U DEMQOL- CH
Year of publication 2005 2005 2013 2013 2019
Target group Persons with 
mild to moderate 
dementia (MMSE 
≥10)
Persons with all stages 
of dementia (up to 
severe)
Same as DEMQOL Same as DEMQOL- 
Proxy
Persons with 
all stages of 







Interview of proxy of 
person with dementia
NA (DEMQOL 
scores are used 
and turned into 
preference- based 
(utility) values)
NA (DEMQOL- Proxy 
scores are used 




care staff proxy 
of person with 
dementia
Number of items 28 31 5 (selected 1 
item out of each 
identified domain)
4 (selected 1 item 
out of each identified 



























Scoring Items are scored 
on a 4- point Likert 
scale ranging 
from 1 to 4; 
Positive items are 
scored reversely 
so lower scores 
always indicate 
worse HRQoL; 
item scores are 
summed (possible 
range 28–112)
Items are scored on 
a 4- point Likert scale 
ranging from 1 to 4; 
Positive items are 
scored reversely so 
lower scores always 
indicate worse 
HRQoL; item scores 
are summed (possible 
range 31–124)





a score between 0 
(death) and 1 (full 
health) is generated





a score between 0 
(death) and 1 (full 
health) is generated
Items are scored 
on a 4- point Likert 
scale ranging 
from 1 to 4; 
Positive items are 
scored reversely 
so lower scores 
always indicate 
worse HRQoL; 
item scores are 
summed (possible 
range 31–124)
Reliability       
  Internal 
consistency
α=0.87 α=0.87–0.92 NA NA α=0.90
  Test–retest ICC=0.76 ICC=0.67–0.84 NA NA ICC=0.72
  Utility scores NA NA 0.243–0.986 0.363–0.937 NA
Validity Correlations 
with QOL- AD 
scores (r=0.54) 
and DQOL items 
(r=0.29–0.45)
Correlations with QOL- 





DCM, Dementia Care Mapping; DQoL, Dementia Quality of Life; HRQoL, health- related quality of life; ICC, Intraclass correlation; MMSE, Mini 
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further research projects and activities to improve QoL of 
people with dementia living in congregate care settings.
Search strategy
Supported by a scientific librarian, we will search the 
databases MEDLINE, EMBASE, PsycInfo, Journals@ovid, 
CINAHL, Abstracts in Social Gerontology, Academic 
Search Complete, Cochrane Library, Scopus, Web of 
Science, ProQuest Dissertations & Theses Global Google 
Scholar and Science Direct. We will search the terms 
DEMQOL or DEM- QOL or Dementia Quality of Life scale 
in the database default fields including title, abstract, 
MeSH/subject heading and author- supplied keyword 
fields, as well as, in the fulltext of records (online supple-
mental appendix 1). We will not limit our search based on 
language and year of publication, and we will search the 
time frame covered by the data bases. We will search refer-
ence lists of all included studies for additional references.
Data management
We will manage references using Rayyan45—a free refer-
ence management software designed for literature 
reviews that facilitates online collaboration and blinding 
of reviewers during screening activities. All references 
including abstracts will be uploaded to Rayyan and title/
abstract and fulltext screening will be done using this 
software. All team members will receive training on the 
application of Rayyan prior to the screening, and we 
will conduct regular meetings and calibration exercises 
to improve application of the inclusion and exclusion 
criteria.
Inclusion and exclusion criteria
Our primary inclusion criterion (table 3) is whether the 
study either (a) reports on the development, validation 
or assessment of feasibility, acceptability or appropriate-
ness of any of the DEMQOL versions available or (b) used 
any of the DEMQOL versions to assess study outcomes. 
Original studies of any design or systematically conducted 
reviews are eligible. If the search specified above iden-
tifies non- peer reviewed references (grey literature), 
we will include these references if they meet our inclu-
sion criteria. We will include studies regardless of the 
country of origin, publication language, study setting or 
population. Languages spoken among members of our 
study team include: Chinese, English, French, German, 
Nepalese and Urdu. Our networks include colleagues 
who speak Danish, Dutch, Farsi, Italian, Norwegian, 
Portuguese, Spanish and Swedish, who will help us to 
assess eligibility of studies in these languages. Should we 
encounter studies with no English abstract in languages 
other than those listed, we will further leverage our 
networks to find a colleague who speaks this language. 
We have successfully applied this approach in previous 
literature reviews.46 47 Studies that assessed HRQoL as a 
study outcome, using either of the DEMQOL instruments 
will be included regardless of the research question(s) 
and regardless of whether HRQoL was the main study 
outcome (dependent variable), an independent variable 
(predictor) or a covariate to adjust models.
Study screening
After removal of duplicates, team member pairs will 
independently screen titles and abstracts of retrieved 
references. Discrepancies will be discussed in the group 
and resolved by consensus. Full texts will be retrieved for 
included references and for references with insufficient 
information in the title/abstract to decide on inclusion. 
Full text screening will follow the same method as title/
abstract screening.
Quality appraisal
To assess the risk of bias of each included study assessing 
the reliability or validity of one of the DEMQOL tools, 
we will use the validated COSMIN risk of bias checklist 
for systematic reviews of Patient‐Reported Outcome 
Measures.48 To assess the risk of bias of each other 
included study, we will use one of four validated check-
lists, as appropriate for the respective study design:
 ► Systematically conducted reviews: Assessment of 
Multiple Systematic Reviews (AMSTAR) tool.49–52
 ► Clinical studies with or without a control group and 
with or without randomised allocation of participants: 
Quality Assessment Tool for Quantitative Studies 
(QATQS).53 54
 ► Cross- sectional studies: Estabrooks’ Quality Assess-
ment and Validity Tool for Cross- Sectional Studies, 
which is based on established criteria for assessing 
quality of research studies.55 56
 ► Qualitative studies: Critical Appraisal Skills 
Programme (CASP) Qualitative Research Checklist.57
Studies will be assessed independently by two team 
members and discrepancies resolved by consensus. We 
will score overall quality of each study, using a method 
we have previously used in various systematic reviews.58–62 
As per the developer of this method,63 we will calculate 
the ratio of the obtained score to the maximum possible 
score for each study (possible range: 0–1). The maximum 
possible score varies depending on the checklist used 
and the number of checklist items applicable. We will 
rank studies as weak (≤0.50), low moderate (0.51–0.66), 
high moderate (0.67–0.79) or strong (≥0.80). We will also 
summarise and describe the key areas of weakness for all 
studies within each type of research design.
Data extraction
Our study team collaboratively adapted and pretested data 
extraction templates (online supplemental appendix 2), 
successfully used in previous systematic reviews.46 47 One 
team member will extract study details into the template, 
and a second team member will double check the 
extracted information and discrepancies will be resolved 
by consensus. We will extract:
 ► First author
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 ► Journal name (or type of reference such as thesis, 
report, textbook)
 ► Country of study
 ► Study aim(s), goal(s), purpose(s) or question(s) 
and which of our review questions these refer to (ie, 
development of the DEMQOL; assessments of its reli-
ability and/or validity; assessments of its feasibility, 
acceptability, appropriateness; use of the DEMQOL as 
dependent study outcome or as covariate
 ► Study design
 ► Study setting and sample
 ► DEMQOL version(s) used
 ► Dependent study variables and how they were meas-
ured (if applicable)
 ► Independent study variables and how they were meas-
ured (if applicable)
 ► Main results as they relate to the development of 
either of the DEMQOL versions; DEMQOL reliability, 
validity; DEMQOL feasibility, acceptability, appro-
priateness; DEMQOL use (operationalised as per 
table 3).
Contacting authors for additional details
If a study does not report enough details, we will contact 
the study authors by email and invite them to clarify or 
add information to inform inclusion or exclusion of this 
study, risk for bias assessments and/or data extractions. In 
the case of non- response, we will send out reminders after 
7, 10 and 13 days.
Analyses
To address research question 1, we will first conduct a 
thematic analysis64 of narrative data (eg, types of research 
questions asked) from the studies that used the DEMQOL 
to assess research outcomes, converting narrative to cate-
gorical data. Using figures and tables, we will descriptively 
present the number and proportion of studies that repre-
sent each category—for example, DEMQOL version used, 
types of research questions asked, participant groups 
included, country of origin, study setting, study design, 
risk for bias category and so on.
To address research question 2, we will use descriptive 
statistics and narrative synthesis to summarise the propor-
tion of studies that have assessed each of the elements 
outlined in table 3 (development, reliability, validity, 
feasibility, acceptability, appropriateness of any of the 
DEMQOL versions), and the range of results reported by 
these studies. We will operationalise these results as per 
table 3 and report them by DEMQOL version used.
For qualitative results, we will conduct a content anal-
ysis of the key themes and supporting data related to the 
respective outcome and whether the content of these 
themes varied across studies. For quantitative results, 
we will report the range of scores, and the number and 
proportion of studies reporting statistically significant 
positive associations, statistically negative associations 
and statistically non- significant associations for a certain 
study outcome (vote counting). We will not attempt to 
synthesise study findings statistically (meta- analyses) 
since our research questions are descriptive, overall effect 
sizes across studies are not part of our two research ques-
tions, and study variables and populations are likely to be 
heterogenous enough that meta- analysis would not be 
appropriate.
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suite of instruments, and recommendations for use in 
practice. Results of this review will synthesise information 
on how DEMQOL has been used and how its psycho-
metric properties have been described or evaluated in 
various studies, which will enable researchers who want to 
use DEMQOL tool in future to evaluate its psychometric 
properties.
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